Bharat Biotech

On R-Day, Bharat Biotech Launches India's First Nasal COVID Vaccine

"Product development and clinical trials for iNCOVACC® were funded in part by the Government of India, through the Department of Biotechnology's, Covid Suraksha Program," the statement informed further.

By Pratidin Time

Jan 26, 2023 18:02 IST logo

3 Min read

Covid 19

Bharat Biotech's Nasal Covid-19 Vaccine iNCOVACC to Cost Rs 800

By Pratidin Time

Dec 27, 2022 14:51 IST logo

2 Min read

National

DCGI Approves Bharat Biotech’s Intranasal Covid-19 Vaccine

By Pratidin Time

Sep 06, 2022 15:55 IST logo

2 Min read

COVID-19: Germany to Recognize Covaxin for Travel from June 1

National

Bharat Biotech’s Covaxin Highly Immunogenic in Children Aged 2-18

By Pratidin Time

Jun 17, 2022 15:28 IST logo

2 Min read

Covid 19

Bharat Biotech Gets Nod for trial of COVID nasal booster dose

By Pratidin Time

Jan 28, 2022 17:48 IST logo

1 Min read

Covid 19

DCGI Approves Bharat Biotech’s Vaccine For Emergency Use In Children Aged 12-18

By Pratidin Bureau

Dec 25, 2021 21:27 IST logo

1 Min read

Covaxin Approval Requested In US For Minors

Covid 19

Bharat Biotech’s Covaxin May Get Final Approval of WHO By October

By Pratidin Bureau

Sep 30, 2021 10:47 IST logo

2 Min read

Covid 19

Brazil Suspends Clinical Trials of Bharat Biotech’s Covaxin

By Pratidin Bureau

Jul 24, 2021 11:42 IST logo

1 Min read

Covid 19

Covaxin Shows 77.8% Overall Efficacy: Bharat Biotech

By Pratidin Bureau

Jul 03, 2021 10:03 IST logo

2 Min read

Health

COVID Vaccine: Covaxin’s Animal Trials Successful

By Pratidin Bureau

Sep 12, 2020 09:34 IST logo

1 Min read